LALPATHLAB2024-07-012024-09-30 LALPATHLAB2024-07-012024-09-30 LALPATHLAB2024-07-012024-09-30in-bse-fin:OneOperatingExpenses01Member LALPATHLAB2024-07-012024-09-30in-bse-fin:OneOperatingExpenses02Member LALPATHLAB2024-07-012024-09-30in-bse-fin:FourOperatingExpenses01Member LALPATHLAB2024-07-012024-09-30in-bse-fin:FourOperatingExpenses02Member LALPATHLAB2024-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 539524 LALPATHLAB NOTLISTED Dr. Lal Path Labs Ltd. Equity 2024-04-01 2025-03-31 2024-10-23 2024-10-16 INR Millions Half yearly 10:30:00 15:25:00 2024-10-23 2024-10-23 true Cash Flow Indirect Not applicable Single segment The business of running laboratories for carrying out Pathological investigations of various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations. 2024-07-01 2024-09-30 Unaudited Standalone 5839000000.00 220000000.00 6059000000.00 1100000000.00 0.00 0.00 1074000000.00 50000000.00 182000000.00 1820000000.00 4226000000.00 1833000000.00 0.00 1833000000.00 442000000.00 39000000.00 481000000.00 0.00 1352000000.00 0.00 0.00 0.00 0.00 1352000000.00 -11000000.00 1341000000.00 0.00 0.00 836000000.00 10 16.24 16.20 0.00 0.00 16.24 16.20 i. The above results were reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 23 October, 2024. The limited review, as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, has been completed by the Statutory Auditors for the quarter and six months ended 30 September, 2024 and they have expressed an unmodified conclusion on the aforesaid results. ii. These financial results have been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. iii. During the six months ended 30 September 2024, the Company has issued 2500 equity shares of face value of Rs. 10 each respectively, on exercise of employee stock options. Further, during the six months ended 30 September 2024, the Company has issued 93,900 equity shares of face value of Rs. 10 each , to Dr. Lal Pathlabs Employee Welfare Trust under Employee Stock Option Plan, 2022 ( ESOP Plan, 2022 ). iv. The Board of Directors of the Company have approved second interim dividend of INR 6per equity share (face value of INR 10 each) at their meeting held on 23 October, 2024 The Board of Directors of the Company had approved an interim dividend of INR 6 per equity share (face value of INR 10 each) at their meeting held on 7 August, 2024 which was paid on 29 August, 2024. The Board of Directors of the Company had proposed final dividend of INR 6 per equity share (face value of INR 10 each) for the financial year ended 31 March, 2024. The same was approved by the shareholders in the Annual General Meeting held on 29 June, 2024 and this was paid on 4 July, 2024. Due to size constraint, we have not pasted complete notes to statement of financial results. Please refer pdf file for complete notes to the statement of Financial Results for the quarter and half year ended September 30, 2024. Single segment 2024-04-01 2024-09-30 Unaudited Standalone 11184000000.00 508000000.00 11692000000.00 2149000000.00 0.00 0.00 2082000000.00 105000000.00 360000000.00 3553000000.00 8249000000.00 3443000000.00 0.00 3443000000.00 847000000.00 15000000.00 862000000.00 0.00 2581000000.00 0.00 0.00 0.00 0.00 2581000000.00 -12000000.00 2569000000.00 0.00 0.00 836000000.00 10 31.01 30.94 0.00 0.00 31.01 30.94 Fees to collection centers/channel partners 879000000.00 Other expenses 941000000.00 Fees to collection centers/channel partners 1667000000.00 Other expenses 1886000000.00 2825000000.00 14000000.00 335000000.00 11000000.00 168000000.00 4000000.00 0.00 0.00 10734000000.00 0.00 0.00 85000000.00 10819000000.00 375000000.00 113000000.00 14664000000.00 372000000.00 2008000000.00 916000000.00 582000000.00 6685000000.00 8000000.00 294000000.00 10493000000.00 0.00 261000000.00 11126000000.00 0.00 0.00 25790000000.00 836000000.00 19907000000.00 20743000000.00 20743000000.00 0.00 0.00 861000000.00 861000000.00 0.00 0.00 0.00 0.00 861000000.00 417000000.00 1907000000.00 1021000000.00 3345000000.00 331000000.00 223000000.00 287000000.00 0.00 4186000000.00 0.00 0.00 5047000000.00 25790000000.00 105000000.00 -96000000.00 -153000000.00 0.00 -69000000.00 0.00 0.00 0.00 0.00 234000000.00 0.00 15000000.00 0.00 360000000.00 0.00 -84000000.00 0.00 16000000.00 0.00 0.00 160000000.00 257000000.00 115000000.00 -72000000.00 0.00 0.00 -17000000.00 -2000000.00 0.00 -65000000.00 3378000000.00 0.00 0.00 0.00 641000000.00 0.00 2737000000.00 0.00 6000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 87000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 45000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 160000000.00 384000000.00 0.00 -4217000000.00 0.00 -3811000000.00 0.00 0.00 57000000.00 0.00 0.00 0.00 0.00 0.00 0.00 417000000.00 0.00 138000000.00 999000000.00 0.00 105000000.00 0.00 -1602000000.00 -2676000000.00 0.00 -2676000000.00 3258000000.00 582000000.00 -14000000.00 -16000000.00 -3000000.00 -4000000.00 0.00 0.00